Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease
The Microbiome Project: microbiota associated to Macula Diseases – µMD
Geographic atrophy phenotype identification by cluster analysis
Drusen Ooze: A Novel Hypothesis in Geographic Atrophy
A Swine Model of Selective Geographic Atrophy of Outer Retinal Layers Mimicking Atrophic AMD: A Phase I Escalating Dose of Subretinal Sodium Iodate
Feeder vessel laser photocoagulation for idiopathic, subfoveal polypoidal choroidal vasculopaty not responding to eithelial growth factor therapy or photodynamic therapy
Direct Visualization of a New Choroidal Vessel on Spectral-Domain Optical Coherence Tomography
Proxima A: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29633)
Proxima B: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29639)
Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.
Correspondence. Wedge-Shaped Subretinal hyporeflectivity in GA.
Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.
Scheduled versus Pro Re Nata Dosing in the VIEW Trials.
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
HARRIER: Clinical trial on patients with choroidal neovascularisation secondary to AMD